These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 23789661

  • 1. Imaging assessment of hepatocellular carcinoma response to locoregional and systemic therapy.
    Yaghmai V, Besa C, Kim E, Gatlin JL, Siddiqui NA, Taouli B.
    AJR Am J Roentgenol; 2013 Jul; 201(1):80-96. PubMed ID: 23789661
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Assessment of tumor response on MR imaging after locoregional therapy.
    Vossen JA, Buijs M, Kamel IR.
    Tech Vasc Interv Radiol; 2006 Sep; 9(3):125-32. PubMed ID: 17561215
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Imaging techniques for the diagnosis of hepatocellular carcinoma and the evaluation of response to treatment.
    Hussain HK, Barr DC, Wald C.
    Semin Liver Dis; 2014 Nov; 34(4):398-414. PubMed ID: 25369302
    [Abstract] [Full Text] [Related]

  • 10. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
    Meza-Junco J, Montano-Loza AJ, Liu DM, Sawyer MB, Bain VG, Ma M, Owen R.
    Cancer Treat Rev; 2012 Feb; 38(1):54-62. PubMed ID: 21726960
    [Abstract] [Full Text] [Related]

  • 11. Hepatocellular carcinoma: locoregional and targeted therapies.
    Wong R, Frenette C, Gish R.
    Gastroenterol Clin North Am; 2011 Sep; 40(3):599-610. PubMed ID: 21893276
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatocellular carcinoma: systemic therapies and future perspectives.
    Mikhail S, Cosgrove D, Zeidan A.
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1205-18. PubMed ID: 25199765
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
    Chapman WC, Majella Doyle MB, Stuart JE, Vachharajani N, Crippin JS, Anderson CD, Lowell JA, Shenoy S, Darcy MD, Brown DB.
    Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Locoregional therapies for hepatocellular carcinoma: which patients are most likely to gain a survival advantage?
    Mahady SE, Charlton B, Fitzgerald P, Koorey DJ, Perry JF, Waugh RC, McCaughan GW, Strasser SI.
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1299-305. PubMed ID: 20594260
    [Abstract] [Full Text] [Related]

  • 17. [Diagnosis and multimodal therapy for hepatocellular carcinoma].
    Kolligs FT, Hoffmann RT, op den Winkel M, Bruns CJ, Herrmann K, Jakobs TF, Lamerz R, Trumm C, Zech CJ, Wilkowski R, Graeb C.
    Z Gastroenterol; 2010 Feb; 48(2):274-88. PubMed ID: 20119895
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
    Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF.
    J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.